biomedicina slovenica


"ACETYLMURAMYL-ALANYL-ISOGLUTAMINE" : 37

  1. Sollner-Dolenc M; Crnošija J; Simčič S; Wraber B; Pečar S
    Influence of desmuramylpeptides from LK-409 series on the cytokine production in the mouse spleen cells
    2006
  2. Gobec Stanislav; Sollner-Dolenc Marija; Urleb Uroš; Wraber Branka; Simčič Saša; Filipič Metka
    Modulation of cytokine production by some phthalimido-desmuramyl dipeptides and their cytotoxicity
    2004
  3. Filipič Metka; Kuhar Polonca; Žegura Bojana; Urleb Uroš; Gobec Stanislav
    Determination of cytotoxic activity of adamantyldesmuramyl didpetides
    2003
  4. Pečar Slavko; Sollner Marija; Urleb Uroš; Kikelj Danijel; Marc Gašper; Krbavčič Aleš; Kotnik Vlado; Wraber-Herzog Branka; Simčič Saša; Ihan Alojz; Klampfer Lidija; Povšič Lučka; Kopitar Zdravko; Štalc Anton
    Novel N-acyldipeptides, and pharmaceutical compositions containing the same
    2001
  5. Urleb Uroš; Gobec Stanislav
    Synthesis of new adamantane substituted acyclic MDP analogs related to LK 415
    [Sinteza novih adamantan substituiranih acikličnih MDP analogov, sorodnih LK 415]
    2000
  6. Sollner Marija; Štalc Anton; Simčič Saša; Wraber Branka; Kotnik Vladimir; Povšič Lučka; Urleb Uroš
    The immunomodulatory characteristics of phthalimido desmuramyl dipeptides
    [Imunomodulacijske karakteristike ftalimido dezmuramil dipeptidov]
    2001
  7. Gobec S; Urleb S; Simčič S; Wraber B
    Synthesis and modulation of cytokine production by two new adamantane substituted acyclic desmuramyldipeptide analogs
    2001
  8. Planinšek Odon; Pišek Robert; Kristl Albin; Schmidt Peter C; Srčić Stanko
    Increased aqueous solubility of N-(7-oxododecanoyl)-L-alanyl-D-isoglutamine by coprecipitating with various pharmaceutical carriers
    [Povečana topnost N-(7-oksododekanoil)-L-alanil-D-izoglutamina v vodi z izdelavo koprecipitatov z različnimi pomožnimi snovmi]
    1999
  9. Gobec Stanislav; Urleb Uroš
    Načrtovanje in sinteza ftalimido in adamantil substituiranih fosforjevih analogov muramil dipeptida
    2000
  10. Simčič Saša; Wraber Branka; Sollner Marja; Urleb Uroš; Gobec Stanislav
    Modulation of tumour necrosis factor production with desmuramyldipeptide analogues
    2000
  11. Sollner M; Pečar S; Štalc A
    The influence of the lipophilicity of 7-oxoacyl-L-alanyl-D-isoglutamines on their immunorestoration activity in vivo
    1996
  12. Urleb Uroš; Gobec Stanislav; Prelog Dušan
    Synthesis and activity of phosphono desmuramyldipeptide analogs
    1995
  13. Tratar Franc; Marc Gašper; Sollner Marija; Kikelj Danijel
    The retro-inverse peptide analogues of N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP)
    1998
  14. Ochi Chizuru; Norisada Nobuyosi; Moriguci Miho; Urleb Uroš; Štalc Anton; Muraoka Shizuko
    Interleukin-10 inducing activity of LK423, a phthalimido-desmuramyldipeptide compound
    1999
  15. Kostanjšek Rok; Kuralt Petra; Malovrh Tadej; Škoberne Mojca; Štalc Anton; Kotnik Vladimir
    MDP desmuramyl analogue LK-404 protects bone marrow and spleen cells from cyclophosphamide induced apoptosis
    1998
  16. Kikelj Danijel; Pečar Slavko; Kotnik Vladimir; Štalc Anton; Wraber-Herzog Branka; Simčič Saša; Ihan Alojz; Klampfer Lidija; Povšič Lučka; Grahek Rok; Suhadolc Elizabeta; Hočevar Mirjam; Hoenig Helmut; Rogi-Kohlenprath Renate
    N-(trans-2-((2'-(acetylamino)cyclohexyl)oxy)acetyl)-L-alanyl-D-glutamic acid: a novel immunologically active carbocyclic muramyl dipeptide analogue
    1998
  17. Kuralt P; Malovrh T; Kostanjšek R; Škoberne M; Štalc A; Kotnik V
    Endoxan induced apoptosis of mice spleen cells and protective role of MPD analogue LK-404
    1997
  18. Kostanjšek R; Malovrh T; Kuralt P; Škoberne M; Štalc A; Kotnik V
    Endoxan induced apoptosis of bone marrow cells, and protective role of MPD analogue LK-404
    1997
  19. Sollner M; Stojičevič M; Pečar S; Štalc A
    Synthesis and biological activity of lipophilic MDP analogue containing the tetrazole moiety
    1997
  20. Štalc A; Kotnik V
    Muramyl dipeptide (MDP) analogues as promising immunomodulating drugs
    1997
  21. Planinšek O; Srčič S; Kristl A
    Increasing solubility of N-(7-oxododecanoyl)-L-alanyl-D-isoglutamine in water solutions
    1997
  22. Kotnik V; Štalc A
    Potential therapeutic indications for synthetic desmuramyl MDP analogue (LK-409)
    1996
  23. Pristovšek P; Kidrič J; Hadži D
    Bioactive conformations of small peptides: a method for selection of candidates based on conformations of active and inactive analogues and its application to muramyl dipeptide
    1995
  24. Sollner M; Pečar S; Povšič L; Štalc A
    Chemical synthesis and immunological characteristics of new acyclic MDP-derivative, LK-404
    1995
  25. Srčič S; Planinšek O; Sollner M; Pečar S
    Termične lastnosti N-(7-oksoacil)-L-alanil-D-izoglutaminov
    [Thermal behaviour of N-(7-oxoacyl)-L-alanyl-D-isoglutamines]
    1996
  26. Novaković S; Rudolf Z
    Role of MDP and its analogues in experimental and clinical oncology
    [Vloga MDP in njegovih analogov v poskusni in klinični onkologiji]
    1995
  27. Kotnik V
    Immunomodulation and immunomodulators
    1994
  28. Novaković S; Boldogh I
    In vitro TNF-alpha production and in vivo alteration of TNF-alpha RNA in mouse peritoneal macrophages after treatment with different bacterial derived agents
    1994
  29. Novaković Srdjan
    Vpliv analogov TNF in MDP na maligne tumorje poskusnih živali
    1994
  30. Serša G; Novaković S; Štalc A
    Antitumor effect of recombinant human tumor necrosis factor-alpha analog combined with desmuramyl dipeptides LK-409 or LK-410 on sarcoma in mice
    1992
  31. Vozelj M; Kotnik V; Wraber B; Koren S; Simčič S; Klampfer L; Ihan A
    Imunomodulatorji in imunomodulacija
    1989
  32. Plečnik M; Ozbič L; Kmetec V
    Zdravilne oblike muramil dipeptidov
    [Application forms of muramyl dipeptides]
    1992
  33. Keglević D; Derome AE
    Synthesis and reactions of O-acetylated benzyl alpha-glycosides of 6-0-(2-acetamido-2-deoxy-beta-D-glucopyranosil)-N-acetylmuramoyl-L-alanyl-D-isoglutamine esters: the base-catalysed isoglutamine in equilibrium glutamine rearrangement in peptidoglycan-related structures
    1989
  34. Tomašić J; Sesartić L; Martin SA; Valinger Z; Ladešić B
    Comparative susceptibility of a peptidoglycan monomer from Brevibacterium divaricatum and its anhydromuramyl analogue to hydrolysis with N-acetylmuramyl-L-alanine amidase. Isolation and characterization of anhydromuramyl-peptidoglycan monomer
    1988
  35. Klampfer L
    Uravnavanje aktivnosti limfocitov B z muramildipeptidi
    1989
  36. Klampfer L; Kotnik V; Ihan A; Wraber B; Simčič S; Vozelj M
    Uravnavanje aktivnosti limfocitov B z muramildipeptidi
    1990
  37. Simčič S; Kotnik V; Ihan A; Wraber B; Klampfer L; Vozelj M
    Vpliv lipopolisaharida, muramildipeptida in strukturnega analoga muramildipeptida-substance S410 na oksidativno eksplozijo mišjih peritonealnih makrofagov
    1990



New search      Comments      Top of page Institute for Biostatistics and Medical Informatics